The DPP4+ASC subtype is associated with a poor prognosis in PAAD and KIRC patients, while the ADIPOQ+Adi subtype is linked to poor survival in melanoma and BRCA patients. This evidence concerns the gene DPP4 and pancreatic adenocarcinoma.